Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | EPOR | P19235 | 2/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27149493 | 0.91 | TLR2 (0.34) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL27150933 | 0.91 | TLR2 (0.34) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL27150935 | 0.91 | TLR2 (0.34) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL27113413 | 0.91 | TLR2 (0.34) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL27145364 | 0.89 | TLR2 (0.33) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL27145367 | 0.89 | TLR2 (0.33) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL31399674 | 0.88 | ALB (0.37) | ALBFOLH1BCHEACHEKDM4E | |
| SCHEMBL15775091 | 0.86 | ALDH1A1 (0.42) | KDM4EALDH1A1EPORTLR2TLR1 | |
| SCHEMBL22076667 | 0.86 | CACNA1H (0.38) | ALBBCHEACHEKDM4EALDH1A1 | |
| SCHEMBL27113557 | 0.86 | CACNA1H (0.38) | ALBBCHEACHEKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078095-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-19 | — | — | US | disclosed |
| EP-3712131-B1 | NEUROTENSIN RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-02-01 | — | — | EP | disclosed |
| US-10961199-B2 | Neurotensin receptor ligands | 3B PHARMACEUTICALS GMBH (DE) | 2021-03-30 | — | — | US | disclosed |
| US-20210087149-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3B Pharmaceuticals (DE) | 2021-03-25 | — | — | US | disclosed |
| US-10799605-B2 | Conjugate comprising a neurotensin receptor ligand and use thereof | 3B PHARMACEUTICALS GMBH (DE) | 2020-10-13 | — | — | US | disclosed |
| EP-3712131-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2020-09-23 | — | — | EP | disclosed |
| EP-2928870-B1 | NEUROTENSIN RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2020-04-08 | — | — | EP | disclosed |
| US-20170119913-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| EP-3154638-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015188934-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2015-12-17 | — | — | WO | disclosed |
| EP-2954934-A1 | Conjugate comprising a neurotensin receptor ligand and use thereof | 3B Pharmaceuticals GmbH (DE) | 2015-12-16 | — | — | EP | disclosed |
| US-20150299133-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3 B Pharmaceuticals GmbH | 2015-10-22 | — | — | US | disclosed |
| EP-2928870-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2015-10-14 | — | — | EP | disclosed |
| WO-2014086499-A1 | NEUROTENSIN RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2014-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087149-A1 | NEUROTENSIN RECEPTOR LIGANDS | NTSR1, NTSR2, TACR3 | ALB 2299/4885FOLH1 1350/4885BCHE 1531/4885 |
| US-20150299133-A1 | NEUROTENSIN RECEPTOR LIGANDS | NTSR1, NTSR2, TACR3 | ALB 2298/4885FOLH1 1359/4885BCHE 1520/4885 |
| US-20170119913-A1 | CONJUGATE COMPRISING A NEUROTENSIN RECEPTOR LIGAND AND USE THEREOF | NTSR1, NTSR2, ADGRF1 | ALB 1695/4885FOLH1 500/4885BCHE 1005/4885 |
| US-10799605-B2 | Conjugate comprising a neurotensin receptor ligand and use thereof | NTSR1, NTSR2, TAAR1 | ALB 1524/4885FOLH1 486/4885BCHE 1038/4885 |
| US-10961199-B2 | Neurotensin receptor ligands | NTSR1, NTSR2, TACR3 | ALB 2298/4885FOLH1 1359/4885BCHE 1520/4885 |
| US-20260078095-A1 | NEUROTENSIN RECEPTOR LIGANDS | NTSR1, NTSR2, GRPR | ALB 2968/4885FOLH1 762/4885BCHE 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.